IBB News Alert Nasdaq Biotechnology Ishares (IBB) 306.20 12/04/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2014 at 6:29 PM

Nasdaq Biotechnology Ishares (IBB) 306.20 $IBB

‘Fast Money’ Recap: Can Stocks Still Rally if Oil Prices Rebound?
at The Street - Wed Dec 03, 4:00AM CST
The trading panel discussed energy stocks, biotechs and Taser.
BIIB: 341.18 (-6.16), ABT: 45.49 (-0.19), VRTX: 118.71 (-1.47), F: 15.81 (-0.20), BMRN: 89.96 (-1.14), RRGB: 71.76 (+0.33), XOP: 49.33 (-1.67), BBRY: 10.47 (-0.45), IBB: 306.20 (-2.05), CP: 194.15 (-3.69), TASR: 24.15 (+1.29), XLE: 81.25 (-0.71), CELG: 113.63 (-0.60)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.08% Gain
Comtex SmarTrend(R) - Tue Dec 02, 3:54PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $303.21 to a high of $307.67. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $307.16 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 306.20 (-2.05)

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.08%
Comtex SmarTrend(R) - Tue Dec 02, 3:53PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $303.21 to a high of $307.67. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $307.16 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 306.20 (-2.05)

Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs
at The Street - Tue Dec 02, 3:30PM CST
Oil prices backtrack from Monday's bounce, but energy stocks shake it off. Instead, the sector gains more than 1% after several weeks of punishing losses.
CY: 12.48 (-0.03), BIIB: 341.18 (-6.16), AVNR: 16.96 (+0.04), XOM: 94.37 (-0.58), IBB: 306.20 (-2.05), FCAU: 13.22 (-0.34), CVX: 112.28 (-1.43), XLE: 81.25 (-0.71), CODE: 29.01 (+0.15)

Biotech Weekly: Biotech From The Charts And What I'm Watching Into Year End
Daniel Ward - at Seeking Alpha - Mon Dec 01, 10:35AM CST

XBI: 178.11 (-1.37), IBB: 306.20 (-2.05), AGIO: 104.05 (+2.03), CELG: 113.63 (-0.60)

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Nov 29, 1:01PM CST
The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called "patent cliff."...
JNJ: 107.56 (-0.16), FLML: 16.84 (+0.10), GERN: 3.50 (-0.10), ICPT: 138.02 (+1.02), IBB: 306.20 (-2.05)

Prepare For A Deflationary Boom?
Leo Kolivakis - at Seeking Alpha - Sat Nov 29, 10:20AM CST
Jon D. Markman of Yahoo Finance reports, Prepare for the rare "deflationary boom" : "Deflation" and "boom" are not two words that normally go together. They are almost like "sad happiness," "low-cal...
XLB: 49.81 (+0.15), QQQ: 105.37 (-0.05), XBI: 178.11 (-1.37), IBB: 306.20 (-2.05), XLK: 42.17 (unch), IWM: 116.81 (-0.56), GSG: 24.50 (-0.12), XLE: 81.25 (-0.71)

Vargatef cleared in Europe for lung cancer
Seeking Alpha - at Seeking Alpha - Fri Nov 28, 8:23AM CST

HTBX: 4.40 (-0.20), BIB: 128.92 (-1.83), INCY: 74.12 (-0.54), PFE: 31.67 (-0.08), IBB: 306.20 (-2.05), DRGS: 54.00 (unch), BIND: 6.14 (-0.58), BMY: 58.89 (-0.14), GSK: 45.89 (-0.82), ONTY: 1.73 (+0.05), ECYT: 6.16 (-0.19), BIS: 46.40 (+0.64), CLVS: 48.63 (-0.15), AZN: 73.94 (+0.12), MRK: 60.92 (+0.34), ARIA: 7.20 (-0.26), IRY: 49.05 (+0.06), IXJ: 103.43 (-0.03), FPRX: 20.65 (-0.25)

How Much Is The Biotech Industry Stretched?
Fred Piard - at Seeking Alpha - Fri Nov 28, 7:11AM CST

BIIB: 341.18 (-6.16), GILD: 101.82 (+0.94), FBT: 101.78 (-0.63), XBI: 178.11 (-1.37), IBB: 306.20 (-2.05), AMGN: 166.55 (-1.52), CELG: 113.63 (-0.60)

UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST

BIS: 46.40 (+0.64), QURE: 12.64 (-0.84), BIB: 128.92 (-1.83), ALXN: 197.66 (-1.22), IBB: 306.20 (-2.05)

China mulling eliminating drug price controls
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:17AM CST

EWH: 21.21 (-0.04), PEK: 41.80 (+1.97), CNXT: 31.21 (+0.67), KBA: 43.63 (+1.77), BIB: 128.92 (-1.83), CQQQ: 35.81 (-0.16), IBB: 306.20 (-2.05), DRGS: 54.00 (unch), CHXF: 52.82 (+1.42), YINN: 34.85 (+2.91), FXP: 44.37 (-2.81), EWHS: 28.39 (unch), PGJ: 29.27 (-0.13), FCA: 23.33 (+0.44), YAO: 28.54 (+0.66), FCHI: 51.42 (+1.38), ASHR: 34.79 (+2.58), ASHS: 37.55 (+0.96), GXC: 80.70 (+1.41), FXI: 41.51 (+1.21), XPP: 67.37 (+3.74), KWEB: 34.71 (-0.31), ECNS: 46.95 (+0.08), TAO: 21.83 (-0.09), CHNA: 32.06 (+1.90), QQQC: 22.48 (-0.07), CHIX: 15.33 (+0.55), KFYP: 66.00 (-1.53), HAO: 27.01 (+0.13), MCHI: 50.40 (+1.17), CHIM: 15.23 (unch), YANG: 12.33 (-1.19), BIS: 46.40 (+0.64), CHIQ: 13.25 (unch), CHIE: 13.75 (unch), FHK: 39.19 (-0.04), CHII: 13.58 (+0.27), YXI: 28.70 (-1.07), CN: 33.93 (+1.19)

Drug makers face pushback on pricey meds
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 7:18AM CST

ABT: 45.49 (-0.19), BIIB: 341.18 (-6.16), BIB: 128.92 (-1.83), PFE: 31.67 (-0.08), AMGN: 166.55 (-1.52), IBB: 306.20 (-2.05), LLY: 72.38 (+1.25), DRGS: 54.00 (unch), GSK: 45.89 (-0.82), BMY: 58.89 (-0.14), CELG: 113.63 (-0.60), JNJ: 107.56 (-0.16), ESRX: 84.03 (-0.27), BIS: 46.40 (+0.64), MRK: 60.92 (+0.34), AZN: 73.94 (+0.12), CVS: 89.84 (+0.70), ABBV: 69.57 (+1.07), SNY: 46.75 (-1.36), IRY: 49.05 (+0.06), IXJ: 103.43 (-0.03), NVS: 95.77 (+0.11)

iShares Nasdaq Biotechnology Index Rises 1.74% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Nov 24, 3:53PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $295.23 to a high of $300.15. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $298.75 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 306.20 (-2.05)

After Yesterday's Rally of 1.74% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 24, 3:52PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $295.23 to a high of $300.15. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $298.75 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 306.20 (-2.05)

Histogenics on deck for IPO
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 3:30PM CST

IPO: 23.43 (-0.18), BIS: 46.40 (+0.64), BIB: 128.92 (-1.83), IBB: 306.20 (-2.05)

Biotech Weekly: The Value In Beaten-Down Biotech IPOs
Daniel Ward - at Seeking Alpha - Mon Nov 24, 8:26AM CST

ROKA: 3.98 (-0.03), NERV: 4.45 (-0.11), IBB: 306.20 (-2.05), REPH: 2.70 (+0.15)

Are Central Banks Panicking?
Leo Kolivakis - Seeking Alpha - Fri Nov 21, 12:50PM CST
Koh Gui Qing and Jason Subler of Reuters report, China surprises with interest rate cut to spur growth : China cut interest rates unexpectedly on Friday, stepping up efforts to support the world's second-biggest economy as it heads towards its...
PGNX: 7.25 (+0.15), BCRX: 9.92 (-0.66), AVNR: 16.96 (+0.04), ACAD: 30.46 (+0.05), IDRA: 4.06 (-0.01), QQQ: 105.37 (-0.05), SGEN: 36.50 (-0.91), XBI: 178.11 (-1.37), TGTX: 13.84 (-0.58), IBB: 306.20 (-2.05), THLD: 3.00 (+0.05), IWM: 116.81 (-0.56), TWTR: 38.79 (-0.27), XOMA: 4.46 (-0.30)

CB Pharma on deck for IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 21, 10:46AM CST

IPO: 23.43 (-0.18), BIS: 46.40 (+0.64), BIB: 128.92 (-1.83), CNDO: 2.32 (-0.02), IBB: 306.20 (-2.05), DRGS: 54.00 (unch), IXJ: 103.43 (-0.03), IRY: 49.05 (+0.06)

CF Foundation sells royalties for $3.3B
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 7:03AM CST

BIS: 46.40 (+0.64), VRTX: 118.71 (-1.47), BIB: 128.92 (-1.83), IBB: 306.20 (-2.05), DRGS: 54.00 (unch), IXJ: 103.43 (-0.03), IRY: 49.05 (+0.06)

Global drug tab will breach trillion dollar mark this year
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 6:41AM CST

BIS: 46.40 (+0.64), IMS: 25.53 (+0.31), PCYC: 139.90 (+0.57), GILD: 101.82 (+0.94), BIB: 128.92 (-1.83), IBB: 306.20 (-2.05), AMGN: 166.55 (-1.52), DRGS: 54.00 (unch), IXJ: 103.43 (-0.03), IRY: 49.05 (+0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Virtual K-Pop Takes U.S. by Storm: HYPEVERSE Emerges

The Rise of Virtual K-Pop Across the Atlantic It's a bold new world for K-pop, and HYPEVERSE is leading the charge. Forget the typical idol group—this one's pulling out all the stops by going virtual and zeroing in on American audiences. Now, as someone who's been burned by the volatility of music stocks in the past, I'm peering at this development with a mix of...

Double Down for Veterans Raises $20 Million Goal

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

AI-Powered Bank Set to Transform Bahrain's Financial Landscape

A Fresh Approach to Banking in Bahrain The stuff that's stirring the pot in Bahrain’s financial sector right now? This big ol' partnership between Mumtalakat, the Kingdom's sovereign wealth fund, and ARP Group. They're on a mission to launch an AI-native wholesale bank smack dab in Bahrain. But here’s the kicker – they’ve got the green light, in principle at...

Envision's 800V DC System Cuts the Powercake First

Envision Hits a Milestone in AI Power Dynamics You ever feel like the future is knocking on your door, but you've still got your headphones on? Well, Envision just kicked the door open with the world's first commercial deployment of an integrated 800-volt direct current (800V DC) power system in a large-scale AI data center. This technological marvel is now up and running...

TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Lazard Closes Deal with Campbell, Launches Lazard CL

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Nanchang Expo Showcases Future of Aviation and Space

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

iQIYI's AI Studio: Future of Filmmaking or Flash in Pan?

Introducing the AI Revolution in Film Here we are, folks, standing at the intersection of film and artificial intelligence. China's entertainment behemoth, iQIYI, has just launched what they're touting as the country's first AI Film Studio over in Shanghai. Kicking things off, they've got "Cop in Trouble" queued up, a film that’s promising to leverage the unbridled...

HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...